Prinivil Related Published Studies
Well-designed clinical trials related to Prinivil (Lisinopril)
Pleural effusions, water balance mediators and the influence of lisinopril after completion Fontan procedures. [2009.07]
Irbesartan improves arterial compliance more than lisinopril. [2009]
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [2008.05]
Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test. [2008]
Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients. [2007.06]
Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. [2007.03]
Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. [2007.01]
Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension. [2006.08]
A randomized, masked, cross-over trial of lisinopril for inflammatory macular edema. [2006.04]
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2006.03]
Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral regurgitation. [2006.02]
Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. [2006.02]
Bioequivalence evaluation of two brands of lisinopril tablets (Lisotec and Zestril) in healthy human volunteers. [2005.11]
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. [2005.08]
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial. [2005.06]
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. [2005.04.06]
Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study. [2005.02]
Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome. [2005.01]
Clarithromycin suspension: bioequivalence studies on two different strengths. [2004.09]
Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials. [2004.09]
Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). [2004.07]
Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria. [2004.06]
Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. [2004.06]
Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. [2004.05]
Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation. [2004.03.15]
Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients. [2004.01]
Evaluation of the bioequivalence and pharmacokinetics of two lisinopril tablet formulations after single oral administration in healthy volunteers. [2004]
Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. [2003.11]
A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. [2003.10]
Blood pressure- and pulse pressure-lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril. [2003.10]
Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension. [2003.09.01]
Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers. [2003.07]
High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. [2003.06]
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design. [2003.06]
Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study. [2003.05]
Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients. [2003.04]
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. [2003.01]
Antihypertensive effects of angiotensin converting enzyme inhibition by lisinopril in post-transplant patients. [2002.10]
Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure. [2002.09.01]
Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. [2002.08.21]
Skeletal muscle magnesium content is correlated with plasma glucose concentration in patients with essential hypertension treated with lisinopril or bendrofluazide. [2002.08]
Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. [2002.05]
Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. [2002.03.06]
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. [2002.02]
Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. [2001.12.15]
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients. [2001.12.01]
Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial. [2001.12]
Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. [2001.11]
Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. [2001.07.15]
Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. [2001.07]
Lisinopril improves endothelial function in chronic cigarette smokers. [2001.07]
Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study. [2001.05]
Reversal of pathophysiologic changes with long-term lisinopril treatment in isolated systolic hypertension. [2001.05]
Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. [2001.05]
Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. [2001.02]
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. [2001.01.22]
Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. [2001.01.06]
Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension. [2001.01]
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. [2000.12.09]
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. [2000.12]
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group. [2000.12]
Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension. [2000.11]
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. [2000.09.19]
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. [2000.08.19]
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. [2000.08.08]
Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism. [2000.08]
Evaluation of amlodipine, lisinopril, and a combination in the treatment of essential hypertension. [2000.06]
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. [2000.04]
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency. [2000.01]
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. [1999.12.07]
Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach. [1999.11]
Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring. [1999.06]
Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril). [1999.05.15]
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. [1999.05]
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus. [1999.05]
Lisinopril improves arterial function in hyperlipidaemia. [1999.05]
The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group. [1999.03]
Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers. [1999.03]
Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy. [1999.03]
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration. [1999.01]
Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy. [1998.12]
Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients. [1998.11]
Buccal absorption of enalapril and lisinopril. [1998.10]
Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. [1998.10]
Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study. [1998.09]
Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. [1998.09]
Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients. [1998.08]
Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures. [1998.06]
Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension. [1998.05]
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators. [1998.03]
Cost-effectiveness analysis of early lisinopril use in patients with acute myocardial infarction. Results from GISSI-3 trial. [1998.03]
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. [1998.01.03]
Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. [1998.01]
Trough to peak ratio of once-daily lisinopril and twice-daily captopril in patients with essential hypertension. [1998.01]
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. [1997.12.16]
Valsartan: long-term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertension. [1997.11]
Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction. [1997.09]
Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group. [1997.09]
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. [1997.08]
Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. [1997.08]
Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension. [1997.07]
|
